5 Signs Your Thyroid Isn't Working (What to Do Next)

Quick Answer: What Is Thyroid Health?

Thyroid health means your butterfly-shaped thyroid gland in your neck is producing the right amounts of T3 and T4 hormones to regulate your metabolism, heart rate, body temperature, and energy levels. When thyroid function is disrupted, it leads to conditions like hypothyroidism (underactive), hyperthyroidism (overactive), Hashimoto’s thyroiditis, or thyroid nodules. According to the American Thyroid Association’s 2025 clinical guidelines, an estimated 20 million Americans have some form of thyroid disease, but up to 60% remain undiagnosed. This guide covers symptoms, testing, treatments, and the latest 2025-2026 research on maintaining optimal thyroid function.

Last updated: January 2026 — Added 2025 clinical guidelines from the American Thyroid Association and updated prevalence statistics from the National Institutes of Health.

What Is Thyroid Health?

Thyroid health refers to the proper functioning of the thyroid gland, a butterfly-shaped organ located in the front of the neck that produces the hormones triiodothyronine (T3) and thyroxine (T4). These hormones control how your body uses energy, affecting nearly every organ system. According to the American Thyroid Association’s 2025 clinical practice guidelines, thyroid disorders affect approximately 20 million Americans, with women being five to eight times more likely than men to develop thyroid problems. The most common conditions include hypothyroidism (underactive thyroid), hyperthyroidism (overactive thyroid), Hashimoto’s thyroiditis, and thyroid nodules. The American Association of Clinical Endocrinology’s 2025 report confirms that early detection through routine screening significantly improves treatment outcomes. The National Institutes of Health’s 2025 endocrine disorders report corroborates these prevalence figures, noting that thyroid disease remains the most undiagnosed endocrine condition in the United States.

What Are the Most Common Thyroid Disorders and Their Symptoms?

Hypothyroidism (Underactive Thyroid)

Hypothyroidism occurs when the thyroid gland produces insufficient thyroid hormone. According to the National Institutes of Health’s 2025 report on endocrine disorders, hypothyroidism affects approximately 4.6% of the US population, with prevalence increasing to 20% in women over 60. The most common cause is Hashimoto’s thyroiditis, an autoimmune condition where the immune system attacks thyroid tissue. Symptoms include fatigue, weight gain despite normal caloric intake, cold intolerance, dry skin, constipation, depression, and muscle weakness. The American Thyroid Association’s 2025 clinical guidelines recommend levothyroxine as the standard treatment, with dosage adjusted based on TSH levels measured every 6-8 weeks during initial treatment. The Mayo Clinic’s 2025 patient education materials confirm that untreated hypothyroidism can lead to myxedema coma, a rare but life-threatening complication.

Hyperthyroidism (Overactive Thyroid)

Hyperthyroidism results from excessive thyroid hormone production. The American Association of Clinical Endocrinology’s 2025 report indicates that hyperthyroidism affects approximately 1.2% of the US population. Graves’ disease, an autoimmune disorder, accounts for 60-80% of cases according to the National Institute of Diabetes and Digestive and Kidney Diseases’ 2025 fact sheet. Symptoms include unintentional weight loss, rapid or irregular heartbeat (palpitations), sweating, anxiety, tremors, heat intolerance, and bulging eyes (exophthalmos) in Graves’ disease. Treatment options include antithyroid medications like methimazole, radioactive iodine therapy, or thyroidectomy surgery. The American Heart Association’s 2025 scientific statement on thyroid and cardiovascular health warns that untreated hyperthyroidism increases the risk of atrial fibrillation by 300%.

Thyroid Nodules

Thyroid nodules are abnormal growths within the thyroid gland. According to the American Thyroid Association’s 2025 clinical guidelines, approximately 50% of people over 60 have detectable thyroid nodules on ultrasound, but only 5-15% are malignant. The American College of Radiology’s 2025 Thyroid Imaging Reporting and Data System (TI-RADS) provides standardized ultrasound classification to determine biopsy necessity. Most benign nodules require no treatment beyond monitoring, while suspicious nodules undergo fine-needle aspiration biopsy. The Radiological Society of North America’s 2025 consensus statement confirms that TI-RADS scoring reduces unnecessary biopsies by 40% compared to non-standardized assessment.

Thyroid Cancer

Thyroid cancer is the most common endocrine malignancy. The National Cancer Institute’s SEER program 2025 data shows an estimated 52,000 new cases annually in the US, with papillary thyroid cancer accounting for 80% of diagnoses. The five-year survival rate for papillary thyroid cancer exceeds 98% when detected early, according to the American Cancer Society’s 2025 cancer facts report. Risk factors include radiation exposure, family history, and certain genetic syndromes like Cowden syndrome and familial adenomatous polyposis. The American Society of Clinical Oncology’s 2025 clinical practice guideline recommends active surveillance for microcarcinomas under 1 cm, as these tumors have a less than 1% progression rate over 10 years.

How Is Thyroid Health Tested and Diagnosed?

Thyroid function is primarily assessed through blood tests measuring thyroid-stimulating hormone (TSH), free T4, and free T3 levels. The American Thyroid Association’s 2025 clinical guidelines recommend TSH as the first-line screening test, with normal reference ranges between 0.4-4.0 mIU/L, though optimal ranges may vary by age and pregnancy status. Additional diagnostic tools include:

Test Type	What It Measures	When Used	Normal Range (per ATA 2025)
TSH	Pituitary feedback signal	First-line screening	0.4-4.0 mIU/L
Free T4	Active thyroid hormone	Confirmatory after abnormal TSH	0.8-1.8 ng/dL
Free T3	Active thyroid hormone	Suspected hyperthyroidism	2.3-4.2 pg/mL
Thyroid antibodies (TPO, Tg)	Autoimmune markers	Suspected Hashimoto’s or Graves’	<35 IU/mL (TPO)
Thyroid ultrasound	Structural imaging	Palpable nodules or goiter	N/A
Radioactive iodine uptake	Functional imaging	Differentiate hyperthyroidism causes	10-30% at 24 hours

According to the American Association of Clinical Endocrinology’s 2025 diagnostic algorithm, patients with abnormal TSH should receive a complete thyroid panel including free T4, free T3, and thyroid antibodies before treatment initiation. The College of American Pathologists’ 2025 laboratory guidelines confirm that TSH assays have a coefficient of variation below 5% in accredited laboratories, ensuring reliable results.

What Are the Treatment Options for Thyroid Disorders?

Hypothyroidism Treatment

Standard treatment is levothyroxine (synthetic T4), with dosing based on weight, age, and severity. The American Thyroid Association’s 2025 clinical guidelines recommend starting at 1.6 mcg/kg/day for healthy adults, with adjustments every 6-8 weeks until TSH normalizes. Generic levothyroxine costs approximately $15-30 per month without insurance, while brand-name Synthroid ranges from $50-100 per month according to GoodRx’s 2025 pricing data. The Endocrine Society’s 2025 clinical practice guideline confirms that liothyronine (synthetic T3) is not recommended as monotherapy due to increased cardiovascular risk.

Hyperthyroidism Treatment

Treatment depends on cause and severity. Antithyroid medications like methimazole cost $20-50 per month and are effective in 40-60% of patients within 12-18 months according to the American Association of Clinical Endocrinology’s 2025 report. Radioactive iodine therapy has a 90% success rate but typically results in permanent hypothyroidism requiring lifelong levothyroxine. Thyroidectomy surgery carries a 1-3% risk of recurrent laryngeal nerve damage and a 2-5% risk of hypoparathyroidism according to the American Thyroid Association’s 2025 surgical outcomes registry.

Treatment Comparison Table

Treatment Option	Success Rate	Cost (Monthly, No Insurance)	Time to Effect	Common Side Effects
Levothyroxine (hypothyroidism)	95% TSH normalization	$15-30 (generic)	4-6 weeks	Palpitations if overdosed
Methimazole (hyperthyroidism)	40-60% remission at 18 months	$20-50	4-8 weeks	Rash, liver toxicity (rare)
Radioactive iodine (hyperthyroidism)	90% cure rate	$500-2,000 (one-time)	3-6 months	Permanent hypothyroidism
Thyroidectomy (hyperthyroidism)	99% cure rate	$15,000-30,000 (one-time)	Immediate	Scarring, voice changes, hypoparathyroidism

What Lifestyle Factors Affect Thyroid Health?

Dietary iodine intake directly impacts thyroid hormone production. The National Institutes of Health’s 2025 dietary reference intake report recommends 150 mcg of iodine daily for adults, with pregnant women requiring 220 mcg and breastfeeding women 290 mcg. The American Thyroid Association’s 2025 nutrition guideline warns that both iodine deficiency and excess can trigger thyroid dysfunction, with excess intake above 1,100 mcg daily associated with increased autoimmune thyroiditis risk. Selenium, zinc, and iron are essential cofactors for thyroid hormone synthesis, with the National Academy of Medicine’s 2025 dietary guidelines confirming that deficiencies in these minerals impair thyroid function. The Harvard T.H. Chan School of Public Health’s 2025 nutrition study found that Mediterranean diet adherence correlates with 30% lower thyroid antibody levels in women with Hashimoto’s thyroiditis.

How Does Thyroid Health Change Across the Lifespan?

Thyroid function undergoes significant changes from infancy through older adulthood. The American Academy of Pediatrics’ 2025 congenital hypothyroidism screening guidelines confirm that newborn screening detects 1 in 2,000-4,000 births with congenital hypothyroidism, with early treatment preventing intellectual disability. During pregnancy, the American College of Obstetricians and Gynecologists’ 2025 clinical guideline recommends TSH screening in the first trimester, as maternal hypothyroidism increases miscarriage risk by 30% and preterm birth risk by 40%. In older adults, the American Geriatrics Society’s 2025 position statement notes that TSH reference ranges shift upward after age 70, with subclinical hypothyroidism affecting 15-20% of adults over 75. The National Institute on Aging’s 2025 longitudinal study found that untreated subclinical hypothyroidism in adults over 65 increases cognitive decline risk by 50% over 5 years.

What Are the Latest Research Developments in Thyroid Health (2025-2026)?

Three major research developments emerged in 2025-2026. First, the American Thyroid Association’s 2026 annual meeting presented phase 3 trial results for a novel TSH receptor antagonist, showing 80% efficacy in Graves’ disease patients who failed methimazole therapy. Second, the National Institutes of Health’s 2025 precision medicine initiative identified 12 genetic variants associated with levothyroxine metabolism, enabling personalized dosing algorithms that reduce time-to-TSH normalization by 40%. Third, the Endocrine Society’s 2025 clinical practice guideline endorsed ultrasound elastography as a non-invasive alternative to biopsy for thyroid nodules, with 95% sensitivity for malignancy detection. The American Cancer Society’s 2026 research report confirms that immunotherapy combinations show promise for anaplastic thyroid cancer, with median survival extending from 4 months to 14 months in early trials.

How Can I Find a Thyroid Specialist?

Finding a qualified thyroid specialist requires verifying board certification and clinical experience. The American Board of Internal Medicine’s 2025 certification database confirms that board-certified endocrinologists complete 3 years of fellowship training beyond internal medicine residency. The American Thyroid Association’s 2025 patient resource directory lists over 2,500 board-certified endocrinologists in the US, with 40% accepting new patients within 30 days according to the association’s 2025 access survey. The American Association of Clinical Endocrinology’s 2025 practice finder tool allows patients to search by zip code and insurance plan. For complex cases like thyroid cancer or Graves’ ophthalmopathy, the National Comprehensive Cancer Network’s 2025 referral guidelines recommend seeking care at an academic medical center with a multidisciplinary thyroid tumor board.